Harold Pollack to Substance Abuse Treatment Centers
This is a "connection" page, showing publications Harold Pollack has written about Substance Abuse Treatment Centers.
Connection Strength
2.892
-
Linkages Between Patient-centered Medical Homes and Addiction Treatment Organizations: Results From a National Survey. Med Care. 2017 04; 55(4):379-383.
Score: 0.596
-
HIV testing and counseling in the nation's outpatient substance abuse treatment system, 1995-2005. J Subst Abuse Treat. 2010 Jun; 38(4):307-16.
Score: 0.364
-
Influence of ownership on access in outpatient substance abuse treatment. J Subst Abuse Treat. 2009 Jun; 36(4):355-65.
Score: 0.342
-
Social costs of robbery and the cost-effectiveness of substance abuse treatment. Health Econ. 2008 Aug; 17(8):927-46.
Score: 0.327
-
Organizational determinants of boundary spanning activity in outpatient substance abuse treatment programmes. Health Serv Manage Res. 2008 Aug; 21(3):168-77.
Score: 0.327
-
Changes in methadone treatment practices: results from a national panel study, 1988-2000. JAMA. 2002 Aug 21; 288(7):850-6.
Score: 0.216
-
Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment Programs. Am J Public Health. 2019 03; 109(3):434-436.
Score: 0.169
-
Do benefits restrictions limit Medicaid acceptance in addiction treatment? Results from a national study. J Subst Abuse Treat. 2018 04; 87:50-55.
Score: 0.158
-
Despite Resources From The ACA, Most States Do Little To Help Addiction Treatment Programs Implement Health Care Reform. Health Aff (Millwood). 2015 May; 34(5):828-35.
Score: 0.130
-
HIV testing in the nation's opioid treatment programs, 2005-2011: the role of state regulations. Health Serv Res. 2014 Feb; 49(1):230-48.
Score: 0.115
-
Case management and client access to health and social services in outpatient substance abuse treatment. J Behav Health Serv Res. 2007 Jul; 34(3):221-36.
Score: 0.076
-
Medicaid coverage in substance use disorder treatment after the affordable care act. J Subst Abuse Treat. 2019 07; 102:1-7.
Score: 0.043
-
Adoption of evidence-based clinical innovations: the case of buprenorphine use by opioid treatment programs. Med Care Res Rev. 2014 Feb; 71(1):43-60.
Score: 0.029